VOLTARENE L.P. 100 mg, extended-release coated tablet 15 tablets
Active ingredients: Diclofenac sodium
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release coated tablet15 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VOLTARENE L.P. 100 mg, comprimé enrobé à libération prolongée
- Pharmaceutical form
- comprimé enrobé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 15 comprimé(s)
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1983
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63225081CIP73246049CIP133400932460496Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DICLOFÉNAC SODIQUEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.